These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Author: Pols H, Verburg K, Hauzer R, Meijer J, Griez E.
    Journal: Biol Psychiatry; 1996 Nov 01; 40(9):913-7. PubMed ID: 8896779.
    Abstract:
    A group of 20 patients who met the DSM-III-R criteria for panic disorder with or without agoraphobia underwent a 35% carbon dioxide (CO2) challenge after either 1 mg alprazolam or placebo in a double-blind, randomized, cross-over design. Despite the anxiolytic potential of alprazolam, it produced no significant effects on CO2-induced anxiety and panic symptomatology when compared to placebo.
    [Abstract] [Full Text] [Related] [New Search]